Cardlytics (CDLX)
(Delayed Data from NSDQ)
$12.31 USD
+0.73 (6.26%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $12.30 -0.01 (-0.08%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Cardlytics, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 92 | 122 | 234 | 293 | 105 |
Receivables | 126 | 120 | 117 | 87 | 85 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 6 | 8 | 8 | 6 | 6 |
Total Current Assets | 224 | 250 | 359 | 386 | 196 |
Net Property & Equipment | 28 | 26 | 24 | 20 | 18 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 4 | 8 |
Intangibles | 312 | 406 | 868 | 0 | 0 |
Deposits & Other Assets | 3 | 3 | 2 | 2 | 2 |
Total Assets | 574 | 691 | 1,264 | 423 | 224 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 4 | 4 | 5 | 1 | 1 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 125 | 136 | 134 | 75 | 77 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 39 | 104 | 182 | 0 | 0 |
Total Current Liabilities | 171 | 249 | 327 | 81 | 78 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 3 |
Convertible Debt | 228 | 226 | 184 | 174 | 0 |
Long-Term Debt | 30 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 4 | 0 | 54 | 1 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 439 | 480 | 573 | 265 | 81 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 1,244 | 1,183 | 1,213 | 551 | 481 |
Retained Earnings | -1,111 | -977 | -523 | -394 | -339 |
Other Equity | 2 | 6 | 0 | 0 | 1 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 135 | 212 | 691 | 157 | 143 |
Total Liabilities & Shareholder's Equity | 574 | 691 | 1,264 | 423 | 224 |
Total Common Equity | 135 | 212 | 691 | 157 | 143 |
Shares Outstanding | 39.20 | 33.10 | 33.20 | 27.40 | 22.80 |
Book Value Per Share | 3.44 | 6.39 | 20.80 | 5.74 | 6.28 |
Fiscal Year End for Cardlytics, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 92 | 90 | 92 | 139 |
Receivables | NA | 126 | 108 | 102 | 99 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 6 | 7 | 8 | 8 |
Total Current Assets | NA | 224 | 206 | 202 | 246 |
Net Property & Equipment | NA | 28 | 27 | 25 | 26 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 312 | 396 | 399 | 403 |
Deposits & Other Assets | NA | 3 | 2 | 2 | 3 |
Total Assets | NA | 574 | 635 | 633 | 685 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 4 | 3 | 2 | 2 |
Current Portion Long-Term Debt | NA | 0 | 30 | 30 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 125 | 116 | 114 | 115 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 39 | 27 | 19 | 70 |
Total Current Liabilities | NA | 171 | 179 | 168 | 191 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 228 | 227 | 227 | 226 |
Long-Term Debt | NA | 30 | 0 | 0 | 30 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 439 | 410 | 397 | 452 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 1,244 | 1,230 | 1,220 | 1,191 |
Retained Earnings | NA | -1,111 | -1,010 | -986 | -963 |
Other Equity | NA | 2 | 5 | 3 | 4 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 135 | 225 | 236 | 232 |
Total Liabilities & Shareholder's Equity | NA | 574 | 635 | 633 | 685 |
Total Common Equity | 0 | 135 | 225 | 236 | 232 |
Shares Outstanding | 44.10 | 39.20 | 37.70 | 33.90 | 33.60 |
Book Value Per Share | 0.00 | 3.44 | 5.98 | 6.96 | 6.91 |